Advertisement.

SNBIF Projected Dividend Yield

SanBio Co Ltd ( OTCBB : SNBIF )

SanBio is a Japanese biopharmaceutical development company. Co. operates its business with a single business segment, regenerative cell therapy using modified allogeneic stem cells. Along with its subsidiaries, Co. focuses on developing products for the diseases related to the central nervous system. Co.'s principal portfolio include SB623 for patients suffering from traumatic brain injury, ischemic stroke, hemorrhagic stroke, dry age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; SB618 for patients suffering from peripheral nerve damage; SB308 for muscle dystrophy; MSC1 for cancer and MSC2 for inflammatory disease.

21 YEAR PERFORMANCE RESULTS

SNBIF Dividend History Detail
SNBIF Dividend News
SNBIF Competitors News

# of Shares: 0

Closing Price: 4.65

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000